%0 Generic
%T Rationale and design of DECISION: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyroid cancer
%A Brose, Marcia S
%A Nutting, Christopher M
%A Sherman, Steven I
%A Shong, Young Kee
%A Smit, Johannes WA
%A Reike, Gerhard
%A Chung, John
%A Kalmus, Joachim
%A Kappeler, Christian
%A Schlumberger, Martin
%I Springer Science and Business Media LLC
%@ 1471-2407
%K Cancer Research
%K Genetics
%K Oncology
%D 2011
%C Springer Science and Business Media LLC
%U http://slubdd.de/katalog?TN_libero_mab2
Download citation